/GRDX
GRDX Stock - GridAI Technologies Corp.
Healthcare|BiotechnologyNASDAQ
$2.33+15.92%
+$0.32 (+15.92%) • Dec 19
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.41
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.74
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.56
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GRDX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.31 – $2.35
TARGET (TP)$2.68
STOP LOSS$2.14
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.15
52W High$5.84
52W Low$0.97
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $-29,274 | $-106,207 | $-537,400 | $-571,145 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-15,621,274 | $-15,770,827 | $-12,678,066 | $-59,056,888 | $-26,432,768 |
| Net Income | $-18,059,336 | $-15,794,983 | $-14,629,642 | $-58,537,849 | $-32,671,466 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-3.88 | $-46.96 | $-407.37 | $-27544.98 | $-56318.94 |
Company Overview
GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GRDXBeat Rate
50%
Last 10 quarters
Avg Surprise
-38.4%
EPS vs Estimate
Beats / Misses
5/5
Last 12 quarters
Latest EPS
$-0.64
Q4 2025
EPS Surprise History
Q1 24
-32.8%
$-5.35vs$-4.03
Q2 24
+115.6%
$0.38vs$-2.43
Q3 24
-147.7%
$-3.84vs$-1.55
Q4 24
-37.5%
$-1.32vs$-0.96
Q2 25
-536.6%
$-2.61vs$-0.41
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q4 2025 | Nov 19, 2025 | — | $-0.64 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-0.14 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.63 | — | — |
Q2 2025 | Apr 4, 2025 | $-0.41 | $-2.61 | -536.6% | ✗ MISS |
Q4 2024 | Nov 13, 2024 | $-0.96 | $-1.32 | -37.5% | ✗ MISS |
Q3 2024 | Aug 26, 2024 | $-1.55 | $-3.84 | -147.7% | ✗ MISS |
Q2 2024 | May 14, 2024 | $-2.43 | $0.38 | +115.6% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $-4.03 | $-5.35 | -32.8% | ✗ MISS |
Q3 2023 | Sep 30, 2023 | $-33.60 | $-9.08 | +73.0% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $-20.80 | $-36.89 | -77.4% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-43.90 | $-35.70 | +18.7% | ✓ BEAT |
Q4 2022 | Dec 31, 2022 | — | $-80.12 | — | — |
Q3 2022 | Sep 30, 2022 | $-421.40 | $378.17 | +189.7% | ✓ BEAT |
Q2 2022 | Jun 30, 2022 | $-2100.00 | $-1041.59 | +50.4% | ✓ BEAT |
Q1 2022 | Mar 31, 2022 | — | $-2601.07 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-3158.65 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-13667.14 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-4988.40 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-5832.11 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GRDX
What is GRDX's current stock price?
GridAI Technologies Corp. (GRDX) is currently trading at $2.33 per share. The stock has moved +15.92% today.
What is the analyst price target for GRDX?
No analyst price targets are currently available for this stock.
What sector is GridAI Technologies Corp. in?
GridAI Technologies Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is GRDX's market cap?
GridAI Technologies Corp. has a market capitalization of $0.01 billion, making it a small-cap company.
Does GRDX pay dividends?
No, GridAI Technologies Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALLR
Allarity Therapeutics, Inc.
$1.03
Mkt Cap: $0.0B
ASBP
Aspire Biopharma Holdings, Inc.
$0.10
Mkt Cap: $0.0B
ATHA
Athira Pharma, Inc.
$6.97
Mkt Cap: $0.0B
BCTX
BriaCell Therapeutics Corp.
$8.95
Mkt Cap: $0.0B
CING
Cingulate Inc.
$3.97
Mkt Cap: $0.0B
CRIS
Curis, Inc.
$1.07
Mkt Cap: $0.0B
CTXR
Citius Pharmaceuticals, Inc.
$1.07
Mkt Cap: $0.0B
LPTX
Leap Therapeutics, Inc.
$1.09
Mkt Cap: $0.0B
PALI
Palisade Bio, Inc.
$1.83
Mkt Cap: $0.3B
PCSA
Processa Pharmaceuticals, Inc.
$3.78
Mkt Cap: $0.0B
Explore stocks similar to GRDX for comparison